| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3052590 | Epilepsy Research | 2010 | 4 Pages |
Abstract
SummaryA study in dogs demonstrated that the commercially available formulation of IV levetiracetam (LEV) could be given safely IM and was quickly and completely absorbed. In this crossover study, 5 women and 5 men were given IM and IV LEV. This study demonstrates that administration of 5 ml (500 mg) IM LEV is well tolerated and its bioavailability is equivalent to an IV injection.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ilo E. Leppik, Varun Goel, John Rarick, Donald R. Nixdorf, James C. Cloyd,